Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT00722137
Brief Title: Study of the Combination of Rituximab, Cyclophosphamide, Doxorubicin, VELCADE, and Prednisone or Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Newly Diagnosed Mantle Cell Lymphoma

First Submitted : July 23, 2008
First Submitted that Met QC Criteria : July 23, 2008
First Posted : July 25, 2008 (Estimate)

Results First Submitted : November 8, 2014
Results First Submitted that Met QC Criteria : November 8, 2014
Results First Posted : November 17, 2014 (Estimate)

Certification/Extension First Submitted : February 1, 2013
Certification/Extension First Submitted that Met QC Criteria : February 1, 2013
Certification/Extension First Posted : February 4, 2013 (Estimate)

Last Update Submitted that Met QC Criteria : June 14, 2018
Last Update Posted : July 12, 2018